ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 209 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $225,000 | -82.6% | 5,498 | -82.9% | 0.00% | -80.0% |
Q1 2021 | $1,296,000 | -90.9% | 32,196 | -86.6% | 0.01% | -92.3% |
Q4 2020 | $14,202,000 | +79.1% | 240,183 | +47.3% | 0.06% | +27.5% |
Q3 2020 | $7,929,000 | +193.6% | 163,044 | +67.7% | 0.05% | +155.0% |
Q1 2020 | $2,701,000 | +5771.7% | 97,230 | +6300.9% | 0.02% | – |
Q4 2019 | $46,000 | -97.6% | 1,519 | -97.6% | 0.00% | -100.0% |
Q3 2019 | $1,941,000 | -79.9% | 62,830 | -68.5% | 0.01% | -81.7% |
Q2 2019 | $9,636,000 | – | 199,500 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |